Wang, A., Dai, H., Gong, Y., Zhang, C., Shu, J., Luo, Y., . . . Bie, P. (2019). ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. J Exp Clin Cancer Res.
Chicago ZitierstilWang, Anbin, Haisu Dai, Yi Gong, Chengcheng Zhang, Junjie Shu, Yuandeng Luo, Yan Jiang, Wei Liu, und Ping Bie. "ANLN-induced EZH2 Upregulation Promotes Pancreatic Cancer Progression By Mediating MiR-218-5p/LASP1 Signaling Axis." J Exp Clin Cancer Res 2019.
MLA ZitierstilWang, Anbin, et al. "ANLN-induced EZH2 Upregulation Promotes Pancreatic Cancer Progression By Mediating MiR-218-5p/LASP1 Signaling Axis." J Exp Clin Cancer Res 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.